Top Markets
Coin of the day
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
Ранг среди акций #39914
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
Цена акции
$0.00366968
Последняя синхронизация: 2024-07-12
Рыночная капитализация
$299.46K
Изменение (1 день)
-66.77%
Изменение (1 год)
0.00%
Страна
CA
Торговля Biocure Technology Inc. (CURE)

Категория

История дивидендов Biocure Technology Inc. (CURE)
Biocure Technology Inc. (тикер: CURE) выплатила в общей сложности 0 дивидендов.
Общая сумма всех дивидендов (с учетом дроблений акций): 0.00
Дивидендная доходность (TTM): 0
Дивидендные выплаты по Biocure Technology Inc. (CURE) с 2026 по 2026
Годовые дивидендные выплаты
Год Дивиденды (с учетом дробления акций) Изменить
Недостаточно данных для указанных дат.
Список всех дивидендных выплат
Год Дивиденд Изменить
Недостаточно данных для указанных дат.
Дивиденды аналогичных компаний или конкурентов
Компания Количество дивидендных выплат Страна
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
29.00%
BE